NEW YORK (GenomeWeb) – N-of-One today announced that it has signed an agreement to provide clinical interpretations for GenomiCare's next-generation sequencing-based oncology panels in China.

N-of-One provides therapeutic strategies relevant to specific cancer cases based on genomic data. Shanghai-based GenomiCare uses NGS to identify mutations and copy number variations across a tumor's exome.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.